Press-release for stocks in the wholesale trade sector related to approval

Prices are updated after-hours

ABVC Announces the Approval of the Plan for GMP Production Facilities of Vitargus by Taiwan Science Park Administration
Published: 2023-08-03 (Crawled : 13:00) - globenewswire.com
ABVC | $1.35 29.81% 23.53% 7.1M

| -55.3% | O: -1.32% H: 5.37% C: 3.36%
vitargus approval

ABVC BioPharma Vitargus® Phase II Study Received Ethical Approval at Sydney Eye Hospital in Australia
Published: 2023-05-22 (Crawled : 12:20) - globenewswire.com
ABVC | $1.35 29.81% 23.53% 7.1M

| 85.03% | O: -0.44% H: 0.0% C: -5.0%
vitargus australia approval hospital biopharma eye study

ABVC BioPharma Receives Australian TGA Approval to Initiate Phase II Study of Vitargus®
Published: 2023-02-21 (Crawled : 14:00) - biospace.com/
ABVC | $1.35 29.81% 23.53% 7.1M

| 86.21% | O: 3.45% H: 10.33% C: 2.67%
vitargus biopharma approval tga study

ABVC BioPharma Provides Vitargus® Update - Phase II Vitargus® Study Protocol Received Thai FDA Approval
Published: 2022-11-17 (Crawled : 14:00) - biospace.com/
ABVC | $1.35 29.81% 23.53% 7.1M

| 73.08% | O: 1.28% H: 0.0% C: -2.53%
vitargus fda biopharma approval update study

ABVC BioPharma Provides ADHD Phase II Part 2 Clinical Study Update and Announces UCSF Institutional Review Board Approval
Published: 2022-09-23 (Crawled : 13:00) - globenewswire.com
ABVC | $1.35 29.81% 23.53% 7.1M

| 66.58% | O: 2.42% H: 25.3% C: 10.06%
biopharma adhd approval review update study

77%

23%

MTTR | News 4 | $4.6 164.37% 62.17% 26M

AGBA | $2.97 137.6% 57.48% 66M

EDBL | News | $6.59 75.27% 41.8% 2M

ZAPP | $4.44 50.2% 33.12% 370K

MTC | $2.24 43.59% 30.67% 6M

OPRT | News | $3.15 40.0% 29.13% 12M

SHIM | $3.045 35.33% 26.23% 870K

HKIT | $1.33 30.39% 24.16% 390K

ABVC | $1.35 29.81% 23.53% 7.1M

OST | $0.5 25.0% 21.88% 280K

Save your searches and get alerts when important news are released.